Posted inPharmaceutical
Mironid LoAc Phase 1 Trial Begins Dosing for ADPKD Drug
Mironid LoAc Phase 1 dosing has begun: the first-in-class PDE4 activator for ADPKD is being tested for safety and pharmacokinetics in healthy volunteers.
Posted inBio Technology
DaltonTx Antibody Discovery Platform Launches AI Workflow
DaltonTx antibody discovery tools combine AI design, structure prediction and validation in one workflow that evaluates millions of sequences in hours.
Posted inPharmaceutical
Foghorn FHD-909 Program Ends With 40% Workforce Cut
Foghorn FHD-909 program ends: Foghorn and Lilly will not advance the SMARCA2 inhibitor after Phase 1 data, and Foghorn will cut about 40% of staff.
Posted inPharmaceutical
Sanofi Regeneron Alliance: Up to $8 Billion Immunology Deal
Sanofi Regeneron alliance expands: Sanofi pays $1 billion upfront and up to $7 billion in milestones for four long-acting immunology antibodies.
Posted inPress Releases
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Vetter is expanding its commercial manufacturing network with plans to add ten new filling lines as pharmaceutical and biotechnology companies seek greater production capacity for increasingly complex drug products. The…
Posted inPress Releases
Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment
Firefly Neuroscience and NeuroSigma are joining forces to expand clinician awareness and patient access to a non-drug treatment option for children with attention-deficit/hyperactivity disorder (ADHD). The strategic partnership will connect…
Posted inPress Releases
InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins
InSilicoTrials has joined a research team led by Sage Bionetworks that has received an award from the Advanced Research Projects Agency for Health (ARPA-H) under its Critical Illness Immunological Reprogramming…
Posted inPress Releases
Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets
Grünenthal and DKSH are expanding their commercial partnership in Asia-Pacific through a new agreement covering four pain medicines, as pharmaceutical companies increasingly look to established regional networks to improve access…
Posted inPress Releases
Marsico Pancreatic Cancer Initiative Expands Multimodal Dataset Across Leading Institutions
The Marsico Pancreatic Cancer Initiative at the University of Colorado Anschutz is expanding into a broader multi-institutional research effort designed to give scientists a deeper view of pancreatic ductal adenocarcinoma…
Posted inPress Releases
Sun Pharma Secures Global Rights to Lerodalcibep in Major Cardiovascular Drug Expansion
Sun Pharmaceutical Industries has entered into an exclusive licensing agreement with LIB Therapeutics to commercialize and manufacture lerodalcibep across global markets outside the United States and China. The agreement gives…